Close Menu

Diagnostics

News and analysis on diagnostic technologies and applications.

The test will be used to identify which advanced or metastatic breast cancer patients with PIK3CA mutations are likely to respond to Novartis' alpelisib.

The researchers have used nCounter, an FDA-cleared platform from NanoString Technologies, to develop their gene expression assay for subtype classification.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

The company received support from a Johns Hopkins University center focused on point-of-care device development for sexually transmitted infections.

The CD Diagnostics lateral flow test detects human alpha defensins proteins in the synovial fluid of patients with a total joint replacement in about 10 minutes.

Jun
17

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.